Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2000 Abstract: 2457: The Antioxidant N-Acetylcysteine Modulates 5-Fluorouracil Activity Against Colorectal Cancer Xenografts in Nude Mice.

Abstracts
2000 Digestive Disease Week

# 2457 The Antioxidant N-Acetylcysteine Modulates 5-Fluorouracil Activity Against Colorectal Cancer Xenografts in Nude Mice.
Simon P. Bach, Sarah T. O’Dwyer, Christopher S. Potten, Alastair J.M. Watson, Liverpool, United Kingdom, Manchester, United Kingdom

Background: The antioxidant pyrrolidinedithiocarbamate (PDTC) promotes cytotoxicity of 5-FU against human colorectal cancer (CRC) xenografts1. This combined treatment is less toxic to normal mouse intestinal epithelium than 5-FU alone2. We investigated the effect of another antioxidant compound, N-acetylcysteine (NAC), upon human CRC xenograft growth in the nude mouse. NAC is of interest as it is licenced for clinical use in high doses to treat acetaminophen poisoning. Method: Athymic nude mice (n=28) were injected subcutaneously, in each flank, with the mutant p53 human CRC cell line HCT 15 (1×106 cells per site). Treatment was administered by intraperitoneal injection on day 7 when the tumours were visible. Groups included: (1) saline 0.2 ml, (2) 5- FU 120 mg/kg, (3) NAC 200mg/kg, (4) NAC and 5-FU. Serial measurements of tumour volume were made in a blinded fashion. Mice were culled when individual tumour volume exceeded 1000mm3. Results: Tumour volume is significantly reduced from day 13 in mice treated with NAC/5-FU compared to those treated with 5-FU alone (day 13, p=0.03; days 17 and 20, p<0.001, Mann-Whitney U test). NAC administered, as a single agent does not retard tumour growth (p=0.31, Mann-Whitney U test). Prior to treatment at day 7, no significant difference exists between groups (p=0.18, Kruskal-Wallis). Conclusion: Growth of established human CRC xenografts was retarded more effectively by combined therapy with NAC/5-FU than with 5-FU alone. Extensive clinical experience with NAC will facilitate development of clinical trials. 1 Chinnery R, Brockman JA, Peeler MO, Shyr Y, Coffey RJ. Nature Medicine 1997; 3(11): 1233-1241. 2 Bach SP, Chinnery R, O’Dwyer ST, Potten CS, Coffey RJ, Watson AJM. Gastroenterology (In press).




Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards